Neuroendocrine Tumour (NET) Unit

Founded in 1997, our neuroendocrine tumour (NET) unit is currently the largest globally, with approximately 2,500 patients under regular follow-ups. Our large clinical research program has international collaborations, and we are the European Centre of Excellence for management of NET.

The aim is to provide optimal management for patients with neuroendocrine tumours, taking into account how the tumour affects each individual.

NET Multidisciplinary Team

We work within a multidisciplinary team and aim to enhance the prospects for treatment by a combination of clinical and laboratory research. The unit and oncology department conducts a number of clinical and basic science research trials relating to the treatment of and the pathogenesis of NET development.

NET multidisciplinary team (MDT) consisting of:

• 3 dedicated gastroenterologists
• 2 oncologists
• 2 endocrinologists
• 2 Hepato-Biliary-Pancreatic (HPB) surgeons
• 2 colorectal surgeons
• 1 cardiologist
• 1 lung physician
• 3 nuclear medicine physicians
• 3 radiologists
• 2 histopathologists
• 3 dedicated NET specialist nurses

As well as:

• Collaborations with Cardio-Thoracic Surgical Departments have been established, through robust treatment pathways, for NET patients who need thoracic or cardiac surgery
• Weekly dedicated NET MDT meeting
• One dedicated carcinoid heart disease MDT per month, with participation of NET physicians, cardiologists and cardiac surgeons.
• World-class care, convenience, comfort and personalised attention